Log In Sign up
The largest database of trusted experimental protocols

Cd8 pacblue

Manufactured by Thermo Fisher Scientific
Visit Supplier

The CD8-PacBlue is a fluorescently labeled antibody that binds to the CD8 protein, which is expressed on the surface of certain T cells. It is commonly used in flow cytometry applications to identify and quantify CD8+ T cells in biological samples.

Automatically generated - may contain errors

Lab products found in correlation

Facsaria, by BD (2 mentions) Cd123 pe cy5, by BD (2 mentions) Cd20 bv570, by BioLegend (2 mentions) Cd4 bv785, by BioLegend (2 mentions) Cd14 bv650, by BioLegend (2 mentions) Cd19 bv605, by BD (2 mentions) Cd27 alx700, by BioLegend (2 mentions) Tcrγδ apc, by BD (2 mentions) Cd16 percp cy5, by BioLegend (2 mentions) Cd32 pe, by BioLegend (2 mentions) Cd45ro ecd, by Beckman Coulter (2 mentions)

2 protocols using cd8 pacblue

1

Isolation and Characterization of CD4+ T Cells

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
Participant recruitment and informed consent were performed under Institutional Review Board (IRB)-approved protocols at the US National Institutes of Health (NIH) and University of Washington. Peripheral blood mononuclear cells (PBMC) were isolated from whole blood by density gradient centrifugation. PBMC were incubated with Fcγ-receptor-blocking reagent for 10 minutes and stained with LIVE/DEAD Aqua stain, CD3-APC-H7 (BD Biosciences; Cat# 641406), CD4-BV785 (BioLegend; Cat# 317442), CD8-PacBlue (Invitrogen; Cat# MHCD0828), CD14-BV650 (BioLegend; Cat# 301836), CD16-PerCP/Cy5.5 (BioLegend; Cat# 302028), CD19-BV605 (BD Biosciences; Cat# 562653), CD20-BV570 (BioLegend; Cat# 302332), CD27-Alx700 (BioLegend; Cat# 302814), CD32-PE (BioLegend; Cat# 303206); CD45RO-ECD (Beckman Coulter; Cat# IM2712U), CD123-PE/Cy5 (BD Biosciences; Cat# 551065), and TCRγδ-APC (BD Biosciences; Cat# 555718). CD4+ T cells were isolated by fluorescence-activated cell sorting (FACS) on a FACSAria (Becton Dickinson) using previously described protocols32 (link).
Sun C., Liu L., Pérez L., Li X., Liu Y., Xu P., Boritz E.A., Mullins J.I, & Abate A.R. (2022). Droplet microfluidic sequencing of HIV proviruses with their integration sites in patients receiving antiretroviral therapy. Nature biomedical engineering, 6(8), 1004-1012.
+ Open protocol
+ Expand
2

Isolation and Characterization of CD4+ T Cells

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
Participant recruitment and informed consent were performed under Institutional Review Board (IRB)-approved protocols at the US National Institutes of Health (NIH) and University of Washington. Peripheral blood mononuclear cells (PBMC) were isolated from whole blood by density gradient centrifugation. PBMC were incubated with Fcγ-receptor-blocking reagent for 10 minutes and stained with LIVE/DEAD Aqua stain, CD3-APC-H7 (BD Biosciences; Cat# 641406), CD4-BV785 (BioLegend; Cat# 317442), CD8-PacBlue (Invitrogen; Cat# MHCD0828), CD14-BV650 (BioLegend; Cat# 301836), CD16-PerCP/Cy5.5 (BioLegend; Cat# 302028), CD19-BV605 (BD Biosciences; Cat# 562653), CD20-BV570 (BioLegend; Cat# 302332), CD27-Alx700 (BioLegend; Cat# 302814), CD32-PE (BioLegend; Cat# 303206); CD45RO-ECD (Beckman Coulter; Cat# IM2712U), CD123-PE/Cy5 (BD Biosciences; Cat# 551065), and TCRγδ-APC (BD Biosciences; Cat# 555718). CD4+ T cells were isolated by fluorescence-activated cell sorting (FACS) on a FACSAria (Becton Dickinson) using previously described protocols32 (link).
Sun C., Liu L., Pérez L., Li X., Liu Y., Xu P., Boritz E.A., Mullins J.I, & Abate A.R. (2022). Droplet microfluidic sequencing of HIV proviruses with their integration sites in patients receiving antiretroviral therapy. Nature biomedical engineering, 6(8), 1004-1012.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!